| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.9 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.032 | 0.9 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.022 | 0.9 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |